Effects of continued use of targeted therapy on patients with pulmonary arterial hypertension and complicated by hemo-ptysis
Zhong-Chao WANG
Xiu-Min HAN
Yao ZUO
Na DONG
Jian-Ming WANG
Li-Li MENG
Jia-Wang XIAO
Ming ZHAO
Yuan MI
Qi-Guang WANG
Abstract：Hemoptysis is a severe complication of pulmonary hypertension (PH) with an incidence of 6%-11%.[1-4] Although occurring in all forms of PH, it is more commonly seen in pulmonary arterial hypertension (PAH), associated with congenital heart disease (PAH-CHD).
Machine-generated Keywords：
Publication Date：2025-03-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 404-410 )